Tasimelteon Oral Suspension

DRUG2 trials

Sponsors

Vanda Pharmaceuticals

Conditions

HealthyInsomnia Disorder

Phase 1

Bioequivalence Study Between Tasimelteon Capsule Formulation and Liquid Suspension Formulation in Healthy Volunteers

CompletedNCT05572281

Vanda PharmaceuticalsHealthy

Start: 2022-05-18End: 2022-06-15Updated: 2024-03-21

Phase 3

Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia

RecruitingNCT06953869

Vanda PharmaceuticalsInsomnia Disorder

Start: 2025-04-21End: 2028-01-01Target: 420Updated: 2026-06-05